Many women thought their health issues were unique until the FDA issued a warning about transvaginal surgical mesh products in late October, citing over one-thousand reports of complications relating to nine different surgical mesh manufacturers, including Bard Avaulta. Note: The FDA has issued another surgical mesh warning in July 2011.
Side Effects and Complications Related to Transvaginal Surgical Mesh Products
The most common complications, which are prompting calls for a recall on these surgical mesh products, include: pain, infection, urinary trouble, recurrence of prolapse and/or incontinence and erosion through the vaginal epithelium. Other complications related to transvaginal placement of surgical mesh in repair of pelvic organ prolapse and stress urinary incontinence includes: bowel and bladder blood vessel perforation during insertion, as well as dyspareunia (pain during intercourse) due to vaginal scarring.
On October 20 the FDA warned healthcare professionals of these dangers, and advised them to obtain specialized training for mesh placement procedures. Healthcare professionals were also advised to “be vigilant for potential adverse events from the mesh, especially erosion and infection” and to “inform patients that implantation of surgical mesh is permanent, and that some complications associated with the implanted mesh may require additional surgery that may or may not correct the complication.”
The FDA also recommended physicians to inform patients considering mesh placement of the potential for the serious, life-altering complications described above.
A pelvic organ prolapse (POP) occurs when a pelvic organ, such as your bladder, drops (“prolapses”) from its normal position and pushes against the walls of your vagina. This can happen if the muscles that hold your pelvic organs in place become weak or stretched from childbirth or surgery. Pelvic organ prolapse can cause pain or problems with bowel and bladder functions or interfere with sexual activity. Bard Avaulta Mesh Products and their counterparts have improved the lives of many women by treating pelvic organ prolapse (POP) and stress urinary incontinence (SUI), two health problems that have been troubling women for many years. Transvaginal surgical mesh products are designed to help manage these conditions and to alleviate the pain and discomfort suffered by women who live with these health problems every day.
However, in treating one health problem many suffering patients claim that they have been exposed to other, often more serious, side effects of transvaginal mesh placement. Patients deserve the right to know of the potential health problems related to products like Bard Avaulta Mesh Product and mesh placement procedures. While transvaginal surgical mesh products have not been recalled as of today (December, 22 2008), the call to have them taken off the market until proven safe are growing. Law firms, such as the one below, are already collecting data from injured patients in regard to Bard Avaulta and other surgical mesh product manufacturers.
You can fill out this form for a free legal consultation about vaginal mesh implants.